Liver stiffness in fibrotic ILD: a CTD-ILD biomarker or a phenotype-dependent signal of systemic fibrosis?
Rheumatology International · 18.07.2026 · 46 (8)
DOI: 10.1007/s00296-026-06248-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift Rheumatology International, online erschienen am 18.07.2026. Verfasst von Yiman Pei. Beteiligte Einrichtung: School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. H19130915307@163.com. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. H19130915307@163.com.
Zitieren
APA
Pei, Y. (2026). Liver stiffness in fibrotic ILD: a CTD-ILD biomarker or a phenotype-dependent signal of systemic fibrosis?. Rheumatology International, 46(8). https://doi.org/10.1007/s00296-026-06248-4
Vancouver
Pei Y. Liver stiffness in fibrotic ILD: a CTD-ILD biomarker or a phenotype-dependent signal of systemic fibrosis?. Rheumatology International. 2026;46(8). doi:10.1007/s00296-026-06248-4
BibTeX
@article{Pei2026,
author = {Pei, Yiman},
title = {Liver stiffness in fibrotic ILD: a CTD-ILD biomarker or a phenotype-dependent signal of systemic fibrosis?},
journal = {Rheumatology International},
year = {2026},
volume = {46},
number = {8},
doi = {10.1007/s00296-026-06248-4}
}
EUVIMED